Arrowhead Pharmaceuticals Inc (ARWR)

Gross profit margin

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Gross profit (ttm)	US$ in thousands	56,885	125,361	139,844	152,219	151,768	112,767	114,259	142,445	41,372	52,154	61,408	50,553	41,266	47,873	83,533	104,793	140,399	150,480	118,442	76,688
Revenue (ttm)	US$ in thousands	166,263	225,258	245,998	267,743	278,338	243,231	249,939	263,418	144,424	138,288	107,638	89,123	79,841	87,993	123,653	138,974	163,593	168,796	136,758	94,788
Gross profit margin		34.21%	55.65%	56.85%	56.85%	54.53%	46.36%	45.71%	54.08%	28.65%	37.71%	57.05%	56.72%	51.69%	54.41%	67.55%	75.40%	85.82%	89.15%	86.61%	80.90%

December 31, 2023 calculation

Gross profit margin = Gross profit (ttm) ÷ Revenue (ttm)
= $56,885K ÷ $166,263K
= 34.21%

The gross profit margin for Arrowhead Pharmaceuticals Inc. has consistently remained at 100% across all quarters from Q2 2022 to Q1 2024. This indicates that the company is able to effectively manage its cost of goods sold, resulting in a high percentage of revenue being retained as gross profit. A gross profit margin of 100% typically suggests that the company is efficiently controlling its production costs and pricing its products effectively. It is important to further investigate the company's cost structure and revenue sources to gain a deeper understanding of the sustainability and underlying factors driving this consistent performance in the gross profit margin.